Development and evaluation of topical formulations that contain hydroethanolic extract from Schinus terebinthifolia against HSV-1 infection

Abstract The therapeutic drugs to treat Herpes simplex virus (HSV) infections have toxic side effects and there has been an emergence of drug-resistant strains. Therefore, the search for new treatments for HSV infections is mounting. In the present study, semi-solid formulations containing a crude h...

Full description

Saved in:
Bibliographic Details
Published inBrazilian Journal of Pharmaceutical Sciences Vol. 58
Main Authors Nocchi, Samara Requena, Ferreira, Lilian dos Anjos Oliveira, Castro-Hoshino, Lidiane Vizioli de, Truiti, Maria da Conceição Torrado, Natali, Maria Raquel Marçal, Mello, João Carlos Palazzo de, Baesso, Mauro Luciano, Dias Filho, Benedito Prado, Nakamura, Celso Vataru, Ueda-Nakamura, Tânia
Format Journal Article
LanguageEnglish
Published Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2022
Subjects
PHARMACOLOGY & PHARMACY
Photoacoustic
Skin irritation
HSV-1
Topical formulations
In vivo efficacy
Schinus terebinthifolia
Online AccessGet full text

Cover

More Information
Summary:Abstract The therapeutic drugs to treat Herpes simplex virus (HSV) infections have toxic side effects and there has been an emergence of drug-resistant strains. Therefore, the search for new treatments for HSV infections is mounting. In the present study, semi-solid formulations containing a crude hydroethanolic extract (CHE) from Schinus terebinthifolia were developed. Skin irritation, cutaneous permeation, and in vivo therapeutic efficacy of the formulations were investigated. Treatment with the ointment formulations did not result in any signs of skin irritation while the emulsions increased the thickness of the epidermis in Swiss mice. The cutaneous permeation test indicated that the CHE incorporated in the formulations permeated through the skin layers and was present in the epidermis and dermis even 3 h after topical application. In vivo antiviral activity in BALB/c mice treated with the CHE ointments was better than those treated with the CHE emulsions and did not significantly differ from an acyclovir-treated group. Taken together, this suggests that the incorporation of CHE in the ointment may be a potential candidate for the alternative topical treatment of herpetic lesions.
ISSN:2175-9790
2175-9790
DOI:10.1590/s2175-97902020000318637